Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

液体ベースの対従来の子宮頸部細胞学.

Peter Sasieni, Hilary Fielder, Bryan Rose

    Lancet (London, England)
    |May 9, 2006
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Association of asymptomatic PSA testing on prostate cancer mortality; a case control study in general practice.

    BJGP open·2026
    Same author

    Cervical cancer mortality trends following HPV vaccination in England, 2001-24: an analysis of population-based mortality data.

    Lancet (London, England)·2026
    Same author

    Vaccination is helping to eliminate cervical cancer in several countries, and continued surveillance is essential.

    BMJ (Clinical research ed.)·2026
    Same author

    Evaluating the Impact of Age on Prostate Cancer Overdiagnosis Using Long-Term Follow-Up From the CAP Randomised Trial.

    International journal of cancer·2026
    Same author

    Implementation of the NHS England Lung Cancer Screening Programme over 5 years.

    Nature medicine·2026
    Same author

    <i>Helicobacter pylori</i> Screen-and-Treat Programs for Gastric Cancer Prevention - IARC Working Group Report.

    The New England journal of medicine·2026
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る